0
Industry
Geography
Report Type
Themes
Price
Publication date
Published Date
  • Sector Analysis

    $2,750 | April 2024
    Sector Analysis

    Italy Cards and Payments – Opportunities and Risks to 2027

    Italy Cards and Payments Market Report Overview The annual value of card transactions in the Italy cards and payments market was $408.5 billion in 2023. The value is expected to grow at a CAGR of more than 10% during 2023-2027. Cash remains an integral part of the Italian consumer payments landscape. The government is making efforts to promote electronic payments including improving payment card acceptance, mandating certain merchant categories to accept electronic payments, and offering tax benefits to merchants for...

  • Product Insights

    New
    $3,500 | June 2024
    Product Insights
    New

    TGF Beta Receptor Type 1 – Drugs In Development, 2024

    The TGF Beta Receptor Type 1 pipeline drugs market research report outlays comprehensive information on the TGF Beta Receptor Type 1 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Respiratory, Dermatology, and Gastrointestinal which include indications of Solid Tumor, Esophageal Cancer, Idiopathic Pulmonary Fibrosis, Pulmonary Fibrosis, Wounds, Keloids, Crohn's Disease (Regional Enteritis), and Oral Mucositis. It...

  • Company Insights

    $350 | March 2024
    Company Insights

    Worldline – Competitor Profile

    Worldline Group is one of the world’s leading payment and transactional service providers, offering end-to-end solutions covering the entire payment value chain. It has omnichannel solutions for merchants, banks, acquirers, payment services providers (PSPs), businesses, and governments. Worldline operates its services in 170 countries, supporting payments in 140 currencies. Worldline operates through three segments—Merchant Services, Financial Services, and Mobility & e-Transactional Services—offering acquiring and processing, card issuing processing, clearing and settlement, open banking, and mobile banking services. Previously, it had...

  • Sector Analysis

    $2,750 | April 2024
    Sector Analysis

    Norway Cards and Payments – Opportunities and Risks to 2027

    Norway Cards and Payments Market Report Overview The annual value of card transactions in the Norway cards and payments market was $121.1 billion in 2023. The value is expected to grow at a CAGR of more than 6% during 2023-2027. The government’s substantial investments in building long-term infrastructure for cashless transactions are driving the gradual rise in the popularity of electronic payments. Moreover, factors such as affordable and widely available financial products, the growing presence of digital-only banks, and consumer...

  • Sector Analysis

    $2,750 | February 2024
    Sector Analysis

    Denmark Cards and Payments – Opportunities and Risks to 2027

    Denmark Cards and Payments Market Report Overview The annual value of card transactions in the Denmark cards and payments market was $109.81 billion in 2023 and will grow at a CAGR of more than 4% during 2023-2027. Rising inflation, unemployment, and ongoing geopolitical uncertainty harmed the cards and payments sector. However, gradual growth in consumer expenditure and purchasing power will drive the sector growth during the forecast period. Denmark Card Transactions Outlook, 2023-2027 ($ Billion) Buy the Full Report for...

  • Company Insights

    $399 | January 2024
    Company Insights

    Innovation and Patenting activity of Nexi SpA Q1 2024

    GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Nexi SpA Q1 2024". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be delivered...

  • Company Insights

    $1,495 | December 2023
    Company Insights

    BNP Paribas – Digital Transformation Strategies

    BNP Paribas Digital Transformation Strategies Report Overview BNP Paribas is investing in AI, cloud, and other digital technologies to develop solutions that can help optimize its banking processes. The annual ICT spending of BNP Paribas was estimated at $2.3 billion for 2023. A major share of this spending is earmarked for acquiring software, network & communications, and hardware from vendors. BNP Paribas offers a range of retail, corporate, and institutional banking solutions. Its retail banking portfolio consists of digital banking,...

  • Company Profile

    $295 | February 2024
    Company Profile

    Nexi SpA – Company Profile

    Nexi SpA (Nexi) is a paytech company that provides payment acceptance solutions. The company nay offers credit cards, debit cards and prepaid cards. Its services include payment and security, merchants and acquiring, digitization and e‑security, corporate banking, network services and POS solutions. The company also provides services including blockchain solutions, ATM and self-banking, compliance and capital markets, clearing and settlement, large databases management, P2P transactions, buy now and pay later, among others. Nexi provides mobile and smartwatch payment, SmartPOS, Mobile...

    Add to Basket
  • Product Insights

    $500 | November 2022
    Product Insights

    Net Present Value Model: NEXI-001

    Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model NEXI-001 Drug Details NEXI-001 (AIM-ACT) is...

  • Product Insights

    $500 | November 2022
    Product Insights

    Net Present Value Model: NEXI-002

    Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model NEXI-002 Drug Details NEXI-002 is under...

Looking to stay on top of industry & market trends?

Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.